New trial results showed statistically significant improvements in overall survival and progression-free survival.
Aislinn Antrim
Advertisement
Articles by Aislinn Antrim
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS
2
PMOS Awareness Month: Watch our expert panel discussion on PMOS
3
Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo
4
Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal
5